Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Hartman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Hypertension|November 1, 1992
Vasopressin gene transcripts in mineralocorticoid hypertension: an in situ studyM D Ashen, R D Hartman, C A Barraclough, et al.
Life Sciences|January 1, 1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseJ J Sramek, R Anand, T S Wardle, et al.
Brain Research|September 10, 1984
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocinJ Y Summy-Long, D S Miller, L M Rosella-Dampman, et al.
Journal of Medicinal Chemistry|March 1, 1983
Piperazinylimidazo[1,2-a]pyrazines with selective affinity for in vitro alpha-adrenergic receptor subtypesW C Lumma, W C Randall, E L Cresson, et al.
Journal of Medicinal Chemistry|January 1, 1981
Piperazinylquinoxalines with central serotoninmimetic activityW C Lumma, R D Hartman, W S Saari, et al.
Schizophrenia Bulletin|January 1, 1996
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalT M Shiovitz, T L Welke, P D Tigel, et al.
Journal of Medicinal Chemistry|June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activityW C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry|December 1, 1984
Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizersG D Hartman, R D Hartman, J E Schwering, et al.
Journal of Medicinal Chemistry|August 1, 1978
Synthesis and antihypertensive activity of some ester progenitors of methyldopaW S Saari, M B Freedman, R D Hartman, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Hypertension|November 1, 1992
Vasopressin gene transcripts in mineralocorticoid hypertension: an in situ studyM D Ashen, R D Hartman, C A Barraclough, et al.
Life Sciences|January 1, 1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseJ J Sramek, R Anand, T S Wardle, et al.
Brain Research|September 10, 1984
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocinJ Y Summy-Long, D S Miller, L M Rosella-Dampman, et al.
Journal of Medicinal Chemistry|March 1, 1983
Piperazinylimidazo[1,2-a]pyrazines with selective affinity for in vitro alpha-adrenergic receptor subtypesW C Lumma, W C Randall, E L Cresson, et al.
Journal of Medicinal Chemistry|January 1, 1981
Piperazinylquinoxalines with central serotoninmimetic activityW C Lumma, R D Hartman, W S Saari, et al.
Schizophrenia Bulletin|January 1, 1996
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalT M Shiovitz, T L Welke, P D Tigel, et al.
Journal of Medicinal Chemistry|June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activityW C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry|December 1, 1984
Synthesis and activity of novel nitropyrazines for use as hypoxic cell radiosensitizersG D Hartman, R D Hartman, J E Schwering, et al.
Journal of Medicinal Chemistry|August 1, 1978
Synthesis and antihypertensive activity of some ester progenitors of methyldopaW S Saari, M B Freedman, R D Hartman, et al.
Pageof 3